Search

Pages

1. • Speech

   • 

   Invited Lecture: Restoring immune control of cancer

   Van den Eynde, Benoît[UCL] (2014) Symposium in honor of Anne-Marie Schmitt-Verhulst — Marseille (France)
2. • Speech

   • 

   Invited lecture: Tumor antigens recognized by T-cells: molecular definition, intracellular processing, and clinical testing as vaccine targets

   Van den Eynde, Benoît[UCL] (2005) Annual Meeting of the American Association for Cancer Research (AACR) — Anaheim, USA
3. • Speech

   • 

   Invited lecture: Expression of IDO in human mature dendritic cells in vivo

   Van den Eynde, Benoît[UCL] Théate, Ivan[UCL] Moulin, Pierre[UCL] Nizet, Yannick[UCL] Renauld, Jean-Christophe[UCL] Larrieu, Pierre[UCL] Hervé, Caroline[UCL] Pilotte, Luc[UCL] (2009) 2nd International IDO Meeting — Bonn, Germany
4. • Speech

   • 

   Invited lecture: Peptide splicing by the proteasome: a new mechanism to produce antigenic peptides presented by MHC class I molecules

   Van den Eynde, Benoît[UCL] Vigneron, Nathalie[UCL] Warren, Edus H Stroobant, Vincent[UCL] Chapiro, Jacques[UCL] Gavin, Marc A[UCL] Riddell, Stanley R Boon, Thierry[UCL] (2004) 8th International Symposium on Dendritic Cells — Brugge, Belgium
5. • Speech

   • 

   Invited lecture: A novel tumor immune escape mechanism based on tryptophan degradation by indoleamine 2,3 dioxygenase

   Van den Eynde, Benoît[UCL] (2003) Keystone Symposium "Cell Biology of the Immune Response" — Keystone, CO, USA
6. • Speech

   • 

   Invited lecture: Processing of tumor antigens and preclinical models for cancer immunotherapy

   Van den Eynde, Benoît[UCL] (2007) Immunology Review Club – Leiden Institute for Immunology - Leiden University — Leiden, The Netherlands
7. • Speech

   • 

   IDO in the tumor microenvironment and targeting it as a treatment

   Van den Eynde, Benoît[UCL] (2016) 2nd Human Cancer Immunology Course for Oncologists and Scientists — Brussels, Belgium
8. • Speech

   • 

   Opportunities and Challenges in the Use of Animal Models for Cancer Target Validation and Drug Development

   Van den Eynde, Benoît[UCL] (2015) AACR Annual meeting 2015 — Philadelphia, USA
9. • Speech

   • 

   Apoptosis of tumor-infiltrating lymphocytes as a druggable immune checkpoint

   Van den Eynde, Benoît[UCL] (2018) Crown Bio Symposium — Antwerpen, Belgium
10. • Speech

    • 

    Invited lecture: Tumor antigens and T lymphocytes

    Van den Eynde, Benoît[UCL] (1999) 6th Study Day of Surgical Oncology — Haasrode, Belgium
11. • Speech

    • 

    Microarray analysis of differential gene expression in B and CD4 T cells of SLE versus control patients

    Lauwerys, Bernard[UCL] Louahed, Jamila[UCL] Van den Eynde, Benoît[UCL] Houssiau, Frédéric[UCL] (2005) Annual European Congress of Rheumatology — Vienna (Austria)
12. • Speech

    • 

    Invited lecture: Genes coding for tumor rejection antigens

    Van den Eynde, Benoît[UCL] (1993) 8th Maimonides Conference on Cancer Research — Ein-Gedi, Israël
13. • Speech

    • 

    Invited lecture: Tumor antigens and mechanisms of tumoral immune resistance

    Van den Eynde, Benoît[UCL] (2009) 5th MUGEN Annual & Review Meeting — Athens, Greece
14. • Speech

    • 

    Invited Lecture: Progresses and challenges in cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2014) Stamcelinstituut conference series — Leuven (Belgium)
15. • Speech

    • 

    Invited lecture: Recognition of tumor antigens

    Van den Eynde, Benoît[UCL] (2000) John Humphrey Course, European Federation of Immunological Societies — Sinaia, Romania
16. • Speech

    • 

    Targeting immunosuppression enzymes in the tumor microenvironment

    Van den Eynde, Benoît[UCL] (2017) ImmunoTherapy of Cancer Conference (ITOC4) — Prague, Czech Republic
17. • Speech

    • 

    Invited lecture: Genes encoding human tumor antigens recognized by cytolytic T lymphocytes

    Van den Eynde, Benoît[UCL] (1994) 13th Meeting of the European Association for Cancer Research — Berlin, Germany
18. • Speech

    • 

    Invited lecture: Tumor antigens and preclinical models for cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2008) BayGene Conference on "Integrative Cancer Genomics" — Munich, Germany
19. • Speech

    • 

    Invited lecture: Tumor antigens recognized by T cells: identification, processing and application in human cancer vaccine trials

    Van den Eynde, Benoît[UCL] (2002) Annual Meeting of the Finnish Society for Immunology — University of Helsinki, Finland
20. • Speech

    • 

    Invited lecture: Boosting cancer immunotherapy by blocking tryptophan degradation

    Van den Eynde, Benoît[UCL] (2012) 7th Annual HBGP Symposium, "Immunity and Inflammation in Disease" — Helsinki, Finland
21. • Speech

    • 

    Invited lecture: Tumor immune resistance based on tryptophan degradation by IDO

    Van den Eynde, Benoît[UCL] (2006) Dutch Tumor Immunology Meeting — Breukelen, The Netherlands
22. • Speech

    • 

    Invited Lecture: Alternative tumour antigens and the tumour proteasome

    Van den Eynde, Benoît[UCL] (2014) ESMO Symposium on Immuno-Oncology — Genève (Switzerland)
23. • Speech

    • 

    Restoring immune control of cancer using small molecule inhibitors of tryptophan catabolism

    Van den Eynde, Benoît[UCL] (2016) Oxford Chemical Immunology Conference — Oxford, England
24. • Speech

    • 

    Targeting IDO and TDO with small molecules to improve cancer immunotherapy

    Van den Eynde, Benoît[UCL] (2017) Medicinal Chemistry Spring Symposium 2017 — Utrecht, The Netherlands
25. • Speech

    • 

    Invited lecture: Genes coding for tumor antigens recognized by T cells

    Van den Eynde, Benoît[UCL] (1993) Cancer Vaccine Symposium — Emeryville-San Francisco, USA

Pages